Nordic Walking

Energy Expenditure

• NEAT accounts for 15-30% of daily EE
• Nordic walking: 20-30% more energy than regular walking
• Upper-body engagement increases total work

Health Benefits

• Improved cardiovascular fitness
• Better glycemic control
• Enhanced functional capacity

Heart failure rehabilitation (RCT)

Keast et al. 2013 (Can J Cardiol; PMID 23773895; keast-2013-nordic-walking-heart-failure-rct-can-j-cardiol) — 54 adults with moderate–severe heart failure (mean LVEF ~27%); 12 weeks of Nordic walking versus standard cardiac rehabilitation matched for 200–400 min/week training time—6-minute walk distance improved more with Nordic walking in abstract-reported group Δ summaries (~126 m vs ~58 m). Single-centre evidence; pair with Liu 2025 older-adult risk-factor meta-analysis rather than merging with healthy step-count cohorts alone.

Step dose, running, and device-measured activity (mortality context)

• Paluch et al. 2022 (Lancet Public Health; PMID 35247352; paluch-2022-daily-steps-all-cause-mortality-lancet-pub) harmonises 15 cohorts for steps/day ↔ all-cause mortality plateaus.
• Pedisic et al. 2020 (Br J Sports Med; PMID 31685526; pedisic-2020-running-dose-mortality-bjsm-meta) pools cohorts for any running vs none on all-cause / CVD / cancer mortality with no significant meta-regression dose trend.
• Ekelund et al. 2019 (BMJ; PMID 31434697; ekelund-2019-accelerometry-pa-sedentary-mortality-bmj) harmonises hip accelerometry for total/light/MVPA and sedentary time ↔ mortality—pair with walking-for-glucose-control when readers mix NEAT, sitting, and post-meal walks.

Recommendations

• 150-300 min/week moderate-to-vigorous activity
• Nordic poles engage triceps, shoulders, and core
• Maintain brisk pace (4-5 km/h)

Older adults — multi-outcome meta-analysis

Liu & Kim 2025 (Arch Gerontol Geriatr; PMID 39476525; liu-2025-nordic-walking-cardiovascular-risk-older-meta) — 22 RCTs, n = 1,271 (mean age ~62 y): pooled SBP −2.92 mmHg (95% CI −5.23 to −0.60), BMI −0.67, weight −1.76 kg, waist −2.21 cm, body fat % −1.54, VO₂-related SMD +0.60 (95% CI 0.11–1.10), and favourable lipid / TG SMDs versus controls; authors highlight DBP gains especially when >65 y—pair with Bullo pole-vs-no-pole contrasts rather than merging with generic step-count cohorts alone.

Bullo et al. 2018 (Rejuvenation Res.; PMID 28756746; bullo-2018-nordic-walking-elderly-meta) synthesized 15 trials (~60–92 y): versus sedentary controls, Nordic walking showed large standardized gains in aerobic capacity, upper- and lower-limb strength, functional balance, lipid-related profiles, and body composition, with a nuanced vs walking-without-poles contrast (better dynamic balance, flexibility, QoL on poles; plain walking slightly stronger for aerobic-capacity ES in that head-to-head). Use as a prescription breadth anchor next to the VO₂-focused ross-2019-nordic row.

Steps, brisk walking, and long-term mortality (shared evidence)

Pole walking still contributes to daily steps and moderate walking minutes. The same burtscher-2020-walking (brisk walking meta-analysis) and bouchard-2011-step-count-mortality (large prospective steps–mortality cohort) linked here are intentionally shared with Walking & glucose control (walking-for-glucose-control) so mortality dose–response is not orphaned when readers start from Nordic walking.

Tertiary map

Wikipedia: Nordic walking (wikipedia-nordic-walking-overview) versus Wikipedia: Walking (wikipedia-walking-overview) keeps pole kinematics and branded trials separate from generic gait literature—glycemic and cardiometabolic effect sizes remain on linked PubMed rows here.

Wikipedia: Green exercise (wikipedia-green-exercise-overview) orients pole-assisted outdoor training next to generic walking-in-nature well-being writing—Bullo et al.-style RCT endpoints remain PubMed-first.

Related registry

Walking & glucose control (walking-for-glucose-control) indexes post-meal walking RCT themes that still apply when the same walks use poles.